Published on in Vol 8, No 12 (2022): December

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/38196, first published .
The Importance of Incorporating At-Home Testing Into SARS-CoV-2 Point Prevalence Estimates: Findings From a US National Cohort, February 2022

The Importance of Incorporating At-Home Testing Into SARS-CoV-2 Point Prevalence Estimates: Findings From a US National Cohort, February 2022

The Importance of Incorporating At-Home Testing Into SARS-CoV-2 Point Prevalence Estimates: Findings From a US National Cohort, February 2022

Saba A Qasmieh   1, 2 , MPH ;   McKaylee M Robertson   1 , MPH, PhD ;   Madhura S Rane   1 , ScM, PhD ;   Yanhan Shen   1, 2 , MS ;   Rebecca Zimba   1, 2 , MHS ;   Camila A Picchio   3 , MPH ;   Angela M Parcesepe   1, 4, 5 , PhD ;   Mindy Chang   1 , DVM, MPH ;   Sarah G Kulkarni   1 , MPH ;   Christian Grov   1, 2 , MPH, PhD ;   Denis Nash   1, 2 , MPH, PhD

1 Institute for Implementation Science in Population Health, City University of New York, New York, NY, United States

2 Graduate School of Public Health and Health Policy, City University of New York, New York, NY, United States

3 Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain

4 Department of Maternal and Child Health, Gillings School of Public Health, University of North Carolina, Chapel Hill, NC, United States

5 Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States

Corresponding Author:

  • Saba A Qasmieh, MPH
  • Institute for Implementation Science in Population Health
  • City University of New York
  • 6th Floor
  • 55 W 125th St
  • New York, NY, 10027
  • United States
  • Phone: 1 646-364-9618
  • Email: saba.qasmieh@sph.cuny.edu